Free Trial

Roche (RHHBY) Insider Trading & Ownership

Roche logo
$40.80 -0.08 (-0.19%)
As of 01:23 PM Eastern

There is no recent insider trading on record for Roche, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public.

Get RHHBY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Roche stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Roche Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction
7/11/2025Ritchie TorresU.S. Congress Member (D-NY)Sell$40.49$1,001 - $15,000
4/21/2025Bruce WestermanU.S. Congress Member (R-AR)Sell$38.80$1,001 - $15,000
4/9/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$37.10$1,001 - $15,000
3/3/2025Bruce WestermanU.S. Congress Member (R-AR)Buy$41.83$1,001 - $15,000
7/23/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$38.20$1,001 - $15,000
6/21/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$35.59$1,001 - $15,000
7/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$37.33$50,001 - $100,000
5/16/2023Josh GottheimerU.S. Congress Member (D-NJ)Sell$39.31$1,001 - $15,000
3/31/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Buy$35.86$1,001 - $15,000
3/27/2023Daniel MeuserU.S. Congress Member (R-PA)Sell$35.10$1,001 - $15,000
2/28/2023Daniel MeuserU.S. Congress Member (R-PA)Sell$36.05$1,001 - $15,000
2/27/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$36.74$15,001 - $50,000
1/13/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Buy$39.43$15,001 - $50,000
11/14/2022Dwight EvansU.S. Congress Member (D-PA)Buy$41.27$1,001 - $15,000
(Data available from 1/1/2013 forward)

RHHBY Insider Trading Activity - Frequently Asked Questions

Bruce Westerman (R-AR) has bought shares of Roche in the last year totaling $8,000. Ritchie Torres (D-NY), Bruce Westerman (R-AR), and Josh Gottheimer (D-NJ) have sold shares totaling $24,000.

Roche Key Executives

  • Dr. Severin Schwan Ph.D. (Age 57)
    Executive Chairman
    Compensation: $8.23M
  • Dr. Thomas Schinecker (Age 49)
    Chief Executive Officer
    Compensation: $4.24M
  • Dr. Alan Hippe (Age 57)
    Chief Financial & Information Officer
    Compensation: $4.5M
  • Dr. Bruno Eschli
    Head of Investor Relations
  • Ms. Claudia Bockstiegel (Age 60)
    General Counsel
  • Ms. Pascale Schmidt (Age 51)
    Chief Compliance Officer
  • Ms. Barbara Schadler (Age 62)
    Head of Group Communications
  • Ms. Cristina A. Wilbur (Age 57)
    Chief People Officer
    Compensation: $3.2M
  • Dr. Nicolas Dunant
    Head of Group Media Relations
  • Mr. Boris L. Zaitra (Age 52)
    Head of Group Business Development and M&A


This page (OTCMKTS:RHHBY) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners